Recent Activity

Loading...

ABOS

Acumen Pharmaceuticals, Inc. · NASDAQ

Performance

+2.24%

1W

+4.29%

1M

+11.28%

3M

+62.95%

6M

-4.95%

YTD

-33.03%

1Y

Profile

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Technical Analysis of ABOS 2024-05-10

Overview:

In analyzing the technical indicators for ABOS stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible future stock price movement. By examining these key indicators, we aim to offer valuable insights and predictions for the upcoming tradin...

See more ...

Recent News & Updates